Akston Biosciences Begins Buildout of New GMP Biologics Manufacturing Facility

Akston Biosciences has signed a lease for an additional 14,000 square feet of space at the Cummings Center in Beverly, MA and started construction of a new GMP biologics manufacturing facility, a GMP quality control laboratory, and a large scale process development laboratory. Dr. Todd Zion, Akston’s co-founder, President, and CEO stated, “These new capabilities will enable the production of GMP drug substance to support the clinical and commercial development of our therapeutics. Having our own facilities and implementing all single-use processing will allow us to better manage our manufacturing costs and timelines across our platform of human and veterinary products.”​